Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Summary

This is a study to be performed in Qatar that will look at the comparison of glycemic control in patients with type 2 diabetes on insulin glargine U100 with insulin degludec over the Ramadan period, to determine whether better glycemic control with fewer hypoglycemic episodes can be achieved.

Timeline

Start

2018-01-07

Primary completion

2018-08-03

Completion

2018-12-31

Drugs

Indications